Griffiths G. D., Phillips G. J., Holley J. Holley inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection // Inhal. Toxicol. 2C07. V. 19. P. 873 -887
Guame-J., Jernigan J. A., Wun-Ju Shieh et al. Pathologyano pathog inesis ofbioterrorism-reiated inhalational anthrax // Amer. J. Pathol. 2003. V. 163. № 2. P. 701–709.
GuamerJ., Zaki S. R. Histopathology and immunohistochemistry in the diagnosis of bioterroiism agents // J. Histochem. Cytochem. 2006. V. 54. № 1. P. 3—11.
Gubser G., Hue S., Kellam P. et al. Poxvirus genomes: a phylogenetic analysis // J. Gen. Virol. 2004. V. 85. P. 105–117.
Guillemin J. Scientists and the history of biological weapons, a brief historical overview cf the development of biological weapons in the twentieth century // EMBO Rep. 2006. V. 7. S45—S49.
Guillemin J. The 1979 anthrax epidemic in the USSR: applied science and political controversy // Proceeding of the American Philosophical Society. 2002. V. 146. № 1. P. 19–36.
Guiyoule A., Gerbaund G., Buchrieser C. et al. Transferable plasmid-mediated resistance of Yersinia pestL // Emerg. Infect. Dis. 2001. V. 7. P. 43–48.
Gyles C. L. Shiga toxin-producing Escherichia coli: An overview // J. Anim. Sci. 2007. V. 85. P. 45–62.
Hacein-Bey-Abina S., Gamgue A., WangC. P. et al. Inserlional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 // J. Clin. Invest. 2008. V. 118. R 3132–3142.
Hacein-Bey-Abina S., Hauer J., Ltm A. et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency // N. Engl. J. Med. — 2010 — V. 363. № 4. F 355–364.
Hacein-Bey-Abina S., le Deist F., CarherF. ei al. Sustained correction of X-hnked severe combined.mmuno-deficiency by ex vivo gene therapy // N. Engl. J. Med. 2002. V. 346. P. 1185–1193.
Hacein-Bey-Abma S., von Kalle C., Schmidt M. ei al. A serious adverse event after successful gene therapy for X-hnked severe combined immunodeficiency // N. Engl. J. Med. 2003. V. 348. № 3. P. 255–256.
Hacem-Bey-Abina S., Von Kalle C., Schmidt M. et al. LM 02-associated cional T-cell proliferation in two patients after gene therapy for SCIDX1 [see comment] // Science 2003. V. 30?. P. 415–419.
Hackstadt Т., Peacock M. G., Hitchcock P. Jet al. Lipopolysaccharide variation in Coxiella hurnettii: intrastrain heterogeneity m structure and antigenicity // Infect. Immun. 1985. V. 48. № 2. P. 359–365.
Haensch S., Bianucci R., Signoli M. et al. Distinct clones, or Yersinia pestis caused the Black Death // PLoS Pathog. 2010. V. 6. № 10. P. elOOl 134. doi: 10.1371/journal.ppat 1001134
Hahn C. S., Lustig S., Strauss E. G. et al. Western equine encephalitis virus is a recombinant virus // Proc. Natl. Acad. Sci. USA. 1988. V. 85. P. 5997–6001.
Halama A., Kulinski M, Librowski T. et al. Polymei based non-viral gene delivery as a concept for the treatment of cancer // Pharm. Rep 2009. V. 61. P. 993–999.
Halfmann P., Kim Jin Hyun, Ebihara H. et al. Generation of biologicallv contained Lbola viruses // Proc. Natl. Acad. Sci. USA. 2008. V. 105. № 4. P. 1129–1133.
HailingS. М., Detillux F. G., Tatum F. M. et al. Deletion of the BCSP31 gene of Brucella abortus by replacement // Infect. Immun. 1991. V. 59. № 11. P. 3863–3868.
Halpem J., Neale E Neurospecific binding internalization and retrograde axonal transport // Cun Top. Microbiol. Immunol. 1995. V. 195. № 1. P. 221–241.
Halstead S. В, Rojanasuphot S., Sangkawibha N. Original antigenic sin in dengue // Am. J. Trap. Med. Hyg. 1983 V. 32. № 1. P. 154–156.
Hanifm С T. The chemical and evolutionary ecology of tetrodotoxin (TTX) toxicity in terrestrial vertebrates // Mar. Drugs. 2010. V. 8. P. 577–593.
Hjolin N. I., Yun N., Zacks M. A. et al. Recombinant alphaviruses are safe and useful serological diagnostic toolls // Am. J. Trop. Med. Hyg. 2007. V. 76. № 4. P. 774–781
Нага T. J. Gustatory detection of tetrodotoxin and saxitoxin, and its competitive inhibition by quinine and strychnine in freshwater fishes // Mar. Drugs. 2011. V 9. P. 2283–2290.
Harty R. No exit: targeting the budding process to inhibit filovirus replication // Antiviral. Res. 2009. V. 81. № 3. P. 189–197.
